Lol, cross promoting. I wouldn't touch MED as I don't trust the management or the way they do business. Too many background dealings.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025